careers faq news & media events contact info site map  
  torrent   torrent pharmaceuticals limited  
 
   
 
Feliz S, Lamitor DT, Clonotril, Storlin, Torplott A
Home  ::  Marketing  ::  Domestic Operations  ::  Division - Alfa  
 

 

Alfa ::

The third new division, Alfa is in the mass products segment and focuses on Gastro, Ortho, and Anti Infectives segments. The gastro-intestinal market is worth around Rs. 3000 crores and is growing at 19%. Alfa will join the existing divisions, Prima and Vista, in this category and is expected to substantially push the revenues from this basket from current Rs. 262 crores (ORG July MAT 2006). The company plans to deploy around 200 new field personnel in this new division to drive growth.

 
 
 » Therapeutic Index
 » Firsts
 » New Launch
 
Divisions
Prima »
Anti-infectives Segment
Vista »
Orthopaedic Segments
Omega »
Cardio-Diabeta Segment
Psycan »
Cardio-Diabeta Segment
Delta »
Cardio-Diabeta Segment
Azuca »
Cardio-Diabeta Segment Segment
Mind »
Central Nervous System Segment
Neuron »
Central Nervous System Segment
Axon »
Central Nervous System Segmenet
Sensa »
Central Nervous System Segment
 
Feliz S
-----------------------------
Lamitor DT
-----------------------------
Clonotril
-----------------------------
Strolin
-----------------------------
Torplott A
-----------------------------
Oleptal DT
-----------------------------
Venlift OD
-----------------------------
Respidon
-----------------------------
Antidep
-----------------------------
Normabrain

 
Copyright © 2003 email
careers faq news & media events contact info site map
^ TOP